• Ferroptosis–Apoptosis Interplay and BH3-Mimetic Modulation i

  2026-04-22

  The referenced study reveals that ferroptosis and apoptosis, previously regarded as distinct cell death modalities, can intersect and influence each other under certain cellular stresses. Importantly, BH3-mimetics—including MCL1 inhibitors—modulate this interplay, sometimes enhancing, altering, or even suppressing cell death outcomes. These findings have significant implications for designing combinatorial cancer therapies targeting mitochondrial apoptotic pathways.

• Technical Guide to Angiotensin I/II (1-5) in RAS Research

  2026-04-22

  Angiotensin I/II (1-5) provides a standardized Asp-Arg-Val-Tyr-Ile peptide fragment for precise modeling of the renin-angiotensin system in hypertension and renal research. It should be used exclusively within workflows investigating blood pressure regulation, aldosterone release, or related peptide signaling, and avoided in unrelated peptide signaling studies due to its narrow mechanistic scope.

• Haloprogin: Applied Antifungal Workflows and Troubleshooting

  2026-04-21

  Haloprogin stands out as a research-standard topical antimicrobial agent with potent activity against dermatophytes, Candida albicans, and Gram-positive bacteria. This article delivers actionable protocols, comparative insights, and troubleshooting solutions for leveraging Haloprogin in advanced infection models and antimicrobial assays.

• HyperScript™ Reverse Transcriptase: Precision in Complex RNA

  2026-04-21

  Explore how HyperScript™ Reverse Transcriptase enables robust cDNA synthesis from challenging RNA templates, highlighting unique assay design strategies and critical insights from recent transcriptomics research. This article reveals advanced applications and benchmarks not covered in existing reviews.

• HyperScribe All in One mRNA Synthesis Kit Plus 1: Translatio

  2026-04-20

  Explore how the HyperScribe All in One mRNA Synthesis Kit Plus 1 empowers precision mRNA vaccine development through advanced ARCA capping and immune-evasive modifications. Learn what sets this kit apart for translational and immunological assay innovation.

• Cy3 NHS Ester (Non-Sulfonated): Technical Guide and Protocol

  2026-04-20

  Cy3 NHS ester (non-sulfonated) addresses the need for efficient, sensitive labeling of amino groups in proteins, peptides, and oligonucleotides for imaging and quantification workflows. It is best used in protocols where organic co-solvents are acceptable, but is not recommended for delicate proteins requiring water-only conditions.

• Applied Workflows for Saquinavir: HIV Protease Inhibitor in

  2026-04-19

  Saquinavir stands out in HIV infection research and permeability modeling, supporting robust, high-throughput workflows from virology to oncology. This article details protocol parameters, troubleshooting, and innovations in biomimetic assay design, translating the latest findings into stepwise lab advantages.

• MPC-Mediated Lactate Drives Histone Lactylation in Colorecta

  2026-04-18

  This study reveals how downregulation of mitochondrial pyruvate carrier (MPC) in colorectal cancer elevates lactate production, which in turn increases histone lactylation in dendritic cells, impairing antitumor immunity. These insights highlight metabolic-epigenetic interactions as potential therapeutic targets for improving immunotherapy outcomes.

• Estradiol, ER Stress, and GPR30 in CD4+ T Cell Recovery Afte

  2026-04-17

  This study demonstrates that 17β-estradiol (E2) restores splenic CD4+ T lymphocyte function after hemorrhagic shock by inhibiting endoplasmic reticulum stress, with effects mediated via ERα and GPR30, but not ERβ. These findings clarify receptor-specific pathways in immune recovery post-trauma and provide mechanistic insight for future cardiovascular and immunological research.

• ARCA-Capped mRNA Synthesis: Mechanistic Leverage for Cancer

  2026-04-16

  This thought-leadership article explores the mechanistic advances and translational strategies enabled by ARCA-capped mRNA synthesis—spotlighting the pivotal role of the HyperScribe™ Co-transcription mRNA Synthesis Kit Plus (ARCA, T7) in next-generation vaccine development. Drawing on recent breakthroughs in hepatocellular carcinoma mRNA nanovaccines, the piece provides actionable guidance for translational researchers seeking robust, high-yield workflows that bridge the bench-to-bedside divide.

• Lactobacillus gasseri Regulates Colitis via NR1I3 and E-cadh

  2026-04-15

  Qian et al. (2024) demonstrate that Lactobacillus gasseri ATCC33323 ameliorates DSS-induced colitis in mice by maintaining intestinal barrier integrity through NR1I3-mediated regulation of E-cadherin. This mechanistic clarification advances our understanding of probiotic intervention in inflammatory bowel disease.

• Nicotinamide Adenine Dinucleotide (NAD+): Optimizing Metabol

  2026-04-14

  Nicotinamide Adenine Dinucleotide (NAD+) from APExBIO drives precision in metabolic signaling and autophagy research, uniquely enabling robust enzymatic workflows. This guide translates new mechanistic insights into actionable protocols and troubleshooting strategies for maximizing experimental success.

• Trametinib (GSK1120212): Optimizing Oncology Research Workfl

  2026-04-13

  Trametinib (GSK1120212) stands out as a highly specific MEK1/2 inhibitor, enabling precise modulation of the MEK-ERK pathway in cell and animal models. This guide details advanced experimental setups, troubleshooting strategies, and key insights from recent telomerase regulation research to maximize Trametinib's impact as an oncology research tool.

• SARS-CoV-2 N Protein Antagonizes GADD34-Mediated Immunity

  2026-04-13

  The referenced study uncovers how the SARS-CoV-2 nucleocapsid (N) protein disrupts host innate immunity by sequestering GADD34 mRNA into atypical stress granule-like foci, impairing IRF3 nuclear translocation and interferon signaling. These findings illuminate a novel viral immune evasion strategy and offer mechanistic insight relevant to antiviral and stress response research.

• Sequential Mitochondrial Transplantation for Cardiac IRI Rep

  2026-04-12

  This study pioneers a sequential mitochondrial transplantation strategy to address acute myocardial ischemia-reperfusion injury (IRI), using engineered nanomotor-modified mitochondria for targeted cardiac delivery. The dual-route administration—intramyocardial followed by intravenous injection—improves cardiomyocyte energy supply, reduces arrhythmogenic risk, and offers a potentially translatable model for cardiac repair.

14926 records 1/996 page Next 12345 下5页 Last page